Valiant Laboratories

Valiant Laboratories

83.34
+1.86
(2.28%)
Market Cap
442.50 Cr
EPS
-0.51
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
124.40
52 Week Low
69.84
PB Ratio
1.44
Debt to Equity
0.42
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
negative
Valiant Laboratories Limited received a show-cause notice from the Assistant Commissioner of CGST & Central Excise, Division-IV, Navi Mumbai Commissionerate. The notice relates to alleged wrong availment of Input Tax Credit on capital goods during the tax period April 2021 to March 2022. The notice proposes disallowance of ITC of ₹64.37 lakhs along with penalty, totaling approximately ₹70.81 lakhs. The company is evaluating appropriate representations regarding the matter.
neutral
Valiant Laboratories Ltd announced management changes approved at their 4th Annual General Meeting held on September 25, 2025. The company re-appointed Mr. Santosh Vora as Managing Director, who was liable to retire by rotation. Mr. Paresh Shah's designation was changed from Executive Director & CFO to Whole-Time Director & CFO, with approval of his remuneration. The company also appointed M/s. Mehta & Mehta as Secretarial Auditors for five consecutive years from FY 2025-26 to FY 2029-30. Mr. Paresh Shah holds a chemical engineering degree and has over 35 years of industry experience, overseeing factory operations and financial activities. Mr. Santosh Vora, the Managing Director, has a commerce degree and over 8 years of experience in chemical and pharmaceutical industry. Both directors confirmed they are not debarred from capital markets by SEBI or other authorities.
neutral
Valiant Laboratories Limited's board approved two key decisions during its August 8, 2025 meeting. The company changed Mr. Paresh Shah's designation from Executive Director to Whole-time Director and Key Managerial Personnel for a five-year term from September 25, 2025 to September 24, 2030. Mr. Shah, a Chemical Engineer with over 35 years of industry experience, oversees factory operations, legal matters, and financial activities including budgeting and project financing. Additionally, the board appointed M/s. Mehta & Mehta as Secretarial Auditors for a five-year term from FY 2025-26 to FY 2029-30. Mehta & Mehta is a Mumbai-based firm with over 25 years of experience specializing in secretarial audit and corporate compliance services. Both appointments are subject to shareholder approval at the upcoming Annual General Meeting.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,636.20
#1 3,82,526.00
34.22
#1 54,729.00
9.71
#1 10,980
-19.84
43.29
5,710.00
1,51,038.30
65.74
9,712.00
18.67
2,191
26.74
28.97
3,567.10
1,21,948.70
59.71
11,539.40
6.99
1,911
19.91
51.91
1,513.00
1,21,429.70
22.68
28,409.50
7.12
5,291
9.88
39.80
1,244.70
1,02,131.70
#1 18.31
33,741.20
16.73
5,725
1.26
34.86
2,439.60
1,00,535.60
53.25
12,744.20
#1 20.90
2,007
-18.14
34.79
991.15
98,802.10
21.41
23,511.00
18.55
4,615
2.60
40.31
1,981.30
87,299.50
24.47
22,909.50
13.74
3,306
#1 51.64
38.96
5,459.50
64,864.00
28.71
13,458.30
3.70
2,216
21.39
52.88
1,086.00
62,953.10
18.78
32,345.60
9.43
3,484
-10.24
49.39
Forecast
Actual
Growth Rate
Revenue Growth
-27.60 %
Net Income Growth
-833.33 %
Cash Flow Change
-30.69 %
ROE
-823.08 %
ROCE
77.27 %
EBITDA Margin (Avg.)
-18.18 %

Quarterly Financial Results

Quarterly Financials
Jun 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
84
72
92
54
63
42
33
22
25
37
56
48
Expenses
79
61
81
48
61
47
35
21
28
35
54
44
EBITDA
4
11
10
6
2
-5
-2
0
-3
2
2
3
Operating Profit %
5 %
14 %
10 %
7 %
-2 %
-16 %
-15 %
-13 %
-31 %
2 %
7 %
5 %
Depreciation
0
0
0
1
1
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
4
10
10
6
1
-5
-3
-0
-4
2
1
3
Tax
1
3
2
2
0
-2
-1
0
1
-1
0
1
Net Profit
3
8
8
4
1
-4
-1
-1
-5
2
1
2
EPS in ₹
1.65
4.70
2.41
1.31
0.24
-0.81
-0.33
-0.13
-1.09
0.54
0.16
0.42

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
213
343
401
Fixed Assets
48
50
48
Current Assets
151
226
193
Capital Work in Progress
1
43
156
Investments
34
38
0
Other Assets
130
212
197
Total Liabilities
213
343
401
Current Liabilities
51
29
60
Non Current Liabilities
62
77
107
Total Equity
101
237
234
Reserve & Surplus
68
193
191
Share Capital
33
44
44

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
-0
11
-7
Investing Activities
-55
-144
-53
Operating Activities
56
2
1
Financing Activities
-1
152
45

Share Holding

% Holding
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Aug 2025
Promoter
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
FIIs
0.00 %
0.00 %
0.00 %
3.48 %
1.89 %
0.00 %
0.00 %
0.64 %
0.63 %
0.52 %
DIIs
3.89 %
0.04 %
0.02 %
0.03 %
0.00 %
0.00 %
0.00 %
0.00 %
0.46 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
12.49 %
12.49 %
13.36 %
15.16 %
16.09 %
17.30 %
17.55 %
16.28 %
17.05 %
17.08 %
Others
8.68 %
12.53 %
11.68 %
6.39 %
7.07 %
7.76 %
7.51 %
8.13 %
6.92 %
7.46 %
No of Share Holders
37,434
37,434
15,821
14,914
14,249
15,189
15,692
15,036
14,432
14,948

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
08 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Aug 2024 132.40 114.95
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 109.94 105.99
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 93.23 99.27
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 100.98 104.48
19 Jul 2025 RIGHTS Rights
1:4
18 Jul 2025 104.70 103.20
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 88.15 91.32
25 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2025 86.49 87.83

Announcements

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20151 day ago
Closure of Trading Window3 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report5 days ago
Announcement under Regulation 30 (LODR)-Change in Management6 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM6 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Letter To ShareholdersSep 01, 2025
Notice Of 4Th Annual General MeetingSep 01, 2025
Reg. 34 (1) Annual Report.Sep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Announcement under Regulation 30 (LODR)-AllotmentAug 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 08, 2025
Appointment Of Secretarial Auditor.Aug 08, 2025
Outcome Of Board Meeting Dated August 08 2025-Financial Results For Quarter Ended June 30 2025Aug 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated August 08 2025 - Financial Results For Quarter Ended June 30 2025Aug 08, 2025
Board Meeting Intimation for Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025Aug 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Submission Of Letter Of Offer For Rights Issue Of Fully Paid-Up Equity Shares Of Valiant Laboratories LimitedJul 17, 2025
Intimation Of ISIN For Right Entitlements For The Purpose Of Right IssueJul 16, 2025
Rights Issue Of Equity Shares - Record Date July 19 2025Jul 15, 2025
Corporate Action-Outcome of Right issueJul 15, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsJul 15, 2025
Board Meeting Outcome for Approval Of Terms Of Rights Issue Of Equity SharesJul 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Draft Letter Of Offer For Proposed Rights Issue Of Equity Shares Jul 10, 2025
Contact Details Of Key Managerial Personnel Of The Company Authorized Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015Jul 09, 2025
Appointment of Company Secretary and Compliance OfficerJul 09, 2025
Announcement under Regulation 30 (LODR)-Raising of FundsJul 09, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On July 09 2025Jul 09, 2025
Board Meeting Intimation for Intimation Of Board Meeting For Fund RaisingJul 05, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJun 26, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMay 20, 2025
Financial Results For The Quarter And Year Ended March 31 2025May 20, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated May 20 2025.May 20, 2025
Board Meeting Intimation for Board Meeting Intimation For Considering And Approving Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025.May 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Integrated Filing (Financial)Feb 07, 2025
Authorised Persons For Determining / Disclosing Material Events / Information.Feb 07, 2025
Financial Results For The Quarter Ended December 31 2024.Feb 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated February 07 2025.Feb 07, 2025
Board Meeting Intimation for Considering And Approving Audited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024.Jan 31, 2025

Technical Indicators

RSI(14)
Neutral
40.58
ATR(14)
Less Volatile
3.91
STOCH(9,6)
Oversold
11.81
STOCH RSI(14)
Oversold
11.71
MACD(12,26)
Bearish
-0.23
ADX(14)
Weak Trend
13.07
UO(9)
Bullish
25.28
ROC(12)
Downtrend And Accelerating
-4.27
WillR(14)
Oversold
-83.23